Rudolph L. Leibel, MD, Named American Diabetes Association’s® 2019 Albert Renold Award Recipient

Rudolph L. Leibel, MD, Named American Diabetes Association’s® 2019 Albert Renold Award Recipient

The American Diabetes Association® (ADA) will present the 2019 Albert Renold Award to Rudolph L. Leibel, MD. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Leibel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco.

Dr. Leibel is the Christopher J. Murphy Memorial Professor of Diabetes Research, Professor of Pediatrics and Medicine, Head of the Division of Molecular Genetics and Co-Director of the Naomi Berrie Diabetes Center at Columbia University.

“Dr. Leibel has been instrumental in carefully crafting a scientific environment in which curiosity is encouraged. He helped establish the Naomi Berrie Fellowship and the Russell Berrie Scholar Programs, each of which support post-doctoral scientists at Columbia University and around the world, and he has overseen more than 50 Berrie Fellows and Scholars over two decades,” said the ADA’s 2019 President of Medicine and Science Louis H. Philipson, MD, PhD, FACP. “Congratulations to Dr. Leibel on this tremendous honor. We are grateful for your many contributions to improving diabetes research, care and training over the twenty years. Mentoring young scientists and building effective teams is the foundation on which future cures will be built.”

Having conducted both basic and clinical research, Dr. Leibel has trained more than 60 graduate students and postdoctoral fellows. His work has helped define key molecular components of the regulatory system that control body weight and adiposity, the inflammatory response to obesity, and the genetic susceptibility to type 2 diabetes. Most recently, Dr. Leibel and his collaborators have used stem cell-based strategies to create and analyze human islet and hypothalamic cells as experimental tools in the analysis of the molecular physiology of diabetes and obesity.

The American Diabetes Association’s 79th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention and care, will be held June 7-11, 2019, at the Moscone Center in San Francisco, California. Nearly 15,000 leading physicians, scientists, health care professionals and industry representatives from around the world are expected to convene at the Scientific Sessions to unveil cutting-edge research, treatment recommendations and advances toward a cure for diabetes. During the five-day meeting, attendees will receive exclusive access to more than 850 presentations and 2,000 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight thematic areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Gretchen Youssef, MS, RDN, CDE, President of Health Care and Education, will deliver her address, “It’s All about Access!,” on Saturday, June 8, and Louis H. Philipson, MD, PhD, FACP, President of Medicine and Science, will address attendees on Sunday, June 9. Join the Scientific Sessions conversation on social media using #ADA2019.

# # #

Press contacts

About the American Diabetes Association

Every day more than 4,000 people are newly diagnosed with diabetes in America. Nearly 115 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For nearly 80 years the ADA has been driving discovery and research to treat, manage and prevent diabetes, while working relentlessly for a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education designed to improve their quality of life. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).